Skip to content

Skin Conditioning

TRANEXAMOYL DIPEPTIDE-35

Updated
85

Safety score · 0–100

Good

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A dipeptide derivative of tranexamic acid used to even tone and reduce dark spots. Skin-level safety is benign; tranexamic acid's prescription status applies to oral/IV doses, not cosmetic concentrations.

Function

HUMECTANT

Skin benefits

  • Targeted brightening
  • Tranexamic-acid-derived tone evening
  • Dipeptide signalling support
  • Well tolerated topically

Known concerns

  • Systemic tranexamic acid is prescription-only (not relevant topically)
  • Limited independent cosmetic clinical data
  • Rare peptide allergy

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related skin conditionings

85
1,10-DECANEDIOL
Skin Conditioning
 85
6-AMINOCAPROIC ACID
Skin Conditioning
 85
ACETYL GLUCOSAMINE
Skin Conditioning
 85
ACETYL HEXAPEPTIDE-7
Skin Conditioning
 85
ALLANTOIN ASCORBATE
Skin Conditioning
 85
ALOE BARBADENSIS EXTRACT
Skin Conditioning
 85
ALOE BARBADENSIS LEAF WATER
Skin Conditioning
 85
ALOE VERA LEAF EXTRACT
Skin Conditioning

Check your shelf

Find TRANEXAMOYL DIPEPTIDE-35 in your products.

Scan any cosmetic product with LuxSense to see if it contains TRANEXAMOYL DIPEPTIDE-35 and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.